Seth Berkley

It's, you know, the poorest countries, they pay something for the doses, but just a little.

We work to drive the prices down.

We work to help them get vaccines out, to help build their systems.

And over time, as they get richer, they pay more and more until they graduate out of Gabi.

So it's some of the best type of development aid.

And it's interesting because, as I said, the U.S.

administration has stopped funding it now.

But during the first administration of the Trump administration, they actually gave Gavi a 5% increase because they said this is exactly the type of development aid we should be doing.

It helps protect Americans by controlling disease.

It helps countries, you know, have a step up, right?

you know, instead of charity.

It allows them to then take over the cost.

And U.S.

was one of many funders.

It wasn't carrying, you know, an unproportional burden.

So I just don't understand.

And this is the problem when you put people in leadership roles who have fixed, you know, a day fix on these issues and come in with bias against them rather than trying to drive forward using the best science.

And science is all we have when we deal with epidemics and pandemics.

You know,

It may change during it.